TLR1/2 orchestrate human plasmacytoid predendritic cell response to gram+ bacteria

por Raieli, Salvatore, Trichot, Coline, Korniotis, Sarantis, Pattarini, Lucia, Soumelis, Vassili
Publicado 2019

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

por Bartolucci, Damiano, Montemurro, Luca, Raieli, Salvatore, Lampis, Silvia, Pession, Andrea, Hrelia, Patrizia, Tonelli, Roberto
Publicado 2022

MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma

por Raieli, Salvatore, Di Renzo, Daniele, Lampis, Silvia, Amadesi, Camilla, Montemurro, Luca, Pession, Andrea, Hrelia, Patrizia, Fischer, Matthias, Tonelli, Roberto
Publicado 2021

Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance

por Bortolotti, Sonia, Angelucci, Silvia, Montemurro, Luca, Bartolucci, Damiano, Raieli, Salvatore, Lampis, Silvia, Amadesi, Camilla, Scardovi, Annalisa, Nieddu, Giammario, Cerisoli, Lucia, Paganelli, Francesca, Chiarini, Francesca, Teti, Gabriella, Falconi, Mirella, Pession, Andrea, Hrelia, Patrizia, Tonelli, Roberto
Publicado 2023

The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma

por Lampis, Silvia, Raieli, Salvatore, Montemurro, Luca, Bartolucci, Damiano, Amadesi, Camilla, Bortolotti, Sonia, Angelucci, Silvia, Scardovi, Anna Lisa, Nieddu, Giammario, Cerisoli, Lucia, Paganelli, Francesca, Valente, Sabrina, Fischer, Matthias, Martelli, Alberto Maria, Pasquinelli, Gianandrea, Pession, Andrea, Hrelia, Patrizia, Tonelli, Roberto
Publicado 2022